CORONA2,200.00

CORONA Remedies Ltd.

· Pharma & Health
₹ CrorePeersERISMANKINDAPLLTDALIVUSAKUMSAGARWALEYEHCGADVENZYMESMcap ₹13,455 Cr
Comp Set
In ₹ Crore except Per Share
Latest Annual
CORONA
FY26
ERIS
FY26
MANKIND
FY26
APLLTD
FY26
Peer
Median
Valuation — at last close
P/E72.68×29.96×48.46×23.80×29.96× +143%
P/B18.02×4.83×5.60×2.83×4.83× +273%
EV/EBITDA46.33×18.80×26.84×15.40×18.80× +146%
Market Cap₹13,455 Cr₹18,808 Cr₹92,715 Cr₹16,058 Cr₹18,808 Cr -28%
Growth
Revenue CAGR 3Y22.92%17.73%9.12%17.73%
Revenue CAGR 5Y20.89%6.37%13.63%
Net Income CAGR 3Y20.06%13.96%25.18%20.06%
Revenue YoY (latest Q)12.97%12.89%25.66%12.97%
Net Income YoY (latest Q)14.56%29.12%12.19%14.56%
Profitability
EBITDA Margin20.91%35.79%25.34%15.23%25.34% -17%
Net Income Margin13.19%20.69%13.57%9.13%13.57% -3%
Return on Common Equity24.79%15.90%11.55%11.83%11.83% +110%
Return on Capital Employed30.28%15.90%12.66%12.97%12.97% +133%
Return on Assets15.36%8.79%6.90%7.66%7.66% +101%
Credit & Quality
Total Debt/Equity0.19×0.59×0.38×0.24×0.38× -50%
Interest Coverage36.67×4.36×4.27×8.54×4.36× +741%
Scale — latest FY
Revenue / Total Income₹1,403 Cr₹3,129 Cr₹14,278 Cr₹7,345 Cr₹7,345 Cr -81%
Net Income₹185 Cr₹648 Cr₹1,938 Cr₹671 Cr₹671 Cr -72%
Total Assets₹1,205 Cr₹7,366 Cr₹28,080 Cr₹8,763 Cr₹8,763 Cr -86%
EPS₹30.27₹45.33₹46.35₹34.33₹45.33 -33%
Book Value per Share₹122.12₹281.28₹401.19₹288.42₹288.42 -58%
◆ best value in the comp set per metric · Δ = subject vs median of the other companies.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.